Xylem Statistics
Total Valuation
Xylem has a market cap or net worth of $34.19 billion. The enterprise value is $35.51 billion.
| Market Cap | 34.19B |
| Enterprise Value | 35.51B |
Important Dates
The last earnings date was Thursday, May 2, 2024.
| Earnings Date | May 2, 2024 |
| Ex-Dividend Date | May 30, 2024 |
Share Statistics
Xylem has 242.45 million shares outstanding. The number of shares has increased by 34.03% in one year.
| Shares Outstanding | 242.45M |
| Shares Change (YoY) | +34.03% |
| Shares Change (QoQ) | +0.21% |
| Owned by Insiders (%) | 0.65% |
| Owned by Institutions (%) | 94.48% |
| Float | 240.62M |
Valuation Ratios
The trailing PE ratio is 49.14 and the forward PE ratio is 32.80. Xylem's PEG ratio is 2.28.
| PE Ratio | 49.14 |
| Forward PE | 32.80 |
| PS Ratio | 4.30 |
| Forward PS | 3.92 |
| PB Ratio | 3.35 |
| P/FCF Ratio | 52.52 |
| PEG Ratio | 2.28 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 27.98, with an EV/FCF ratio of 54.55.
| EV / Earnings | 53.56 |
| EV / Sales | 4.47 |
| EV / EBITDA | 27.98 |
| EV / EBIT | 46.79 |
| EV / FCF | 54.55 |
Financial Position
The company has a current ratio of 1.67, with a Debt / Equity ratio of 0.22.
| Current Ratio | 1.67 |
| Quick Ratio | 1.11 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | 1.79 |
| Debt / FCF | 3.49 |
| Interest Coverage | 14.06 |
Financial Efficiency
Return on equity (ROE) is 6.60% and return on invested capital (ROIC) is 5.51%.
| Return on Equity (ROE) | 6.60% |
| Return on Assets (ROA) | 4.10% |
| Return on Capital (ROIC) | 5.51% |
| Revenue Per Employee | $345,609 |
| Profits Per Employee | $28,826 |
| Employee Count | 23,000 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 5.30 |
Taxes
In the past 12 months, Xylem has paid $42.00 million in taxes.
| Income Tax | 42.00M |
| Effective Tax Rate | 5.96% |
Stock Price Statistics
The stock price has increased by +40.74% in the last 52 weeks. The beta is 1.08, so Xylem's price volatility has been similar to the market average.
| Beta (1Y) | 1.08 |
| 52-Week Price Change | +40.74% |
| 50-Day Moving Average | 134.33 |
| 200-Day Moving Average | 113.50 |
| Relative Strength Index (RSI) | 54.91 |
| Average Volume (30 Days) | 1,166,044 |
Short Selling Information
The latest short interest is 4.33 million, so 1.78% of the outstanding shares have been sold short.
| Short Interest | 4.33M |
| Short Previous Month | 4.28M |
| Short % of Shares Out | 1.78% |
| Short % of Float | 1.80% |
| Short Ratio (days to cover) | 3.41 |
Income Statement
In the last 12 months, Xylem had revenue of $7.95 billion and earned $663.00 million in profits. Earnings per share was $2.87.
| Revenue | 7.95B |
| Gross Profit | 2.92B |
| Operating Income | 730.00M |
| Pretax Income | 705.00M |
| Net Income | 663.00M |
| EBITDA | 1.27B |
| EBIT | 759.00M |
| Earnings Per Share (EPS) | $2.87 |
Balance Sheet
The company has $947.00 million in cash and $2.27 billion in debt, giving a net cash position of -$1.32 billion or -$5.46 per share.
| Cash & Cash Equivalents | 947.00M |
| Total Debt | 2.27B |
| Net Cash | -1.32B |
| Net Cash Per Share | -$5.46 |
| Equity / Book Value | 10.20B |
| Book Value Per Share | 42.05 |
| Working Capital | 1.56B |
Cash Flow
In the last 12 months, operating cash flow was $945.00 million and capital expenditures -$294.00 million, giving a free cash flow of $651.00 million.
| Operating Cash Flow | 945.00M |
| Capital Expenditures | -294.00M |
| Free Cash Flow | 651.00M |
| FCF Per Share | $2.69 |
Margins
Gross margin is 36.77%, with operating and profit margins of 9.18% and 8.34%.
| Gross Margin | 36.77% |
| Operating Margin | 9.18% |
| Pretax Margin | 8.87% |
| Profit Margin | 8.34% |
| EBITDA Margin | 15.96% |
| EBIT Margin | 9.55% |
| FCF Margin | 8.19% |
Dividends & Yields
This stock pays an annual dividend of $1.44, which amounts to a dividend yield of 1.02%.
| Dividend Per Share | $1.44 |
| Dividend Yield | 1.02% |
| Dividend Growth (YoY) | 9.52% |
| Years of Dividend Growth | 12 |
| Payout Ratio | 50.17% |
| Buyback Yield | -34.03% |
| Shareholder Yield | -33.01% |
| Earnings Yield | 1.94% |
| FCF Yield | 1.90% |
Analyst Forecast
The average price target for Xylem is $142.50, which is 1.05% higher than the current price. The consensus rating is "Buy".
| Price Target | $142.50 |
| Price Target Difference | 1.05% |
| Analyst Consensus | Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (5Y) | 8.05% |
| EPS Growth Forecast (5Y) | 18.63% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Xylem has an Altman Z-Score of 4.59 and a Piotroski F-Score of 4.
| Altman Z-Score | 4.59 |
| Piotroski F-Score | 4 |